Shanghai Junshi Biosciences
Shanghai Junshi Biosciences is a biopharmaceutical company.
Business Model:
Revenue: $244.3M
Employees: 1,001-5,000
Rankings
Industries / Tags:
Detailed Shanghai Junshi Biosciences Information
Geographic Data
Address: No. 6, Lane 100, Pingjiaqiao Road
City: Shanghai
State: shanghai municipality
Zip: 201800
Country: CN
Financial Info
Stage:
Raised Last:
$0
Raised Total:$538M
Social
Linkedin
Crunchbase
Metrics
8,054,185Website Global Rank
559Website Monthly Traffic
Twitter Followers
Description
Junshi Bio is a China-based biopharmaceutical company that develops molecule and antibody drugs for cancer treatments.
Contact Phone:
Contact Email:
Shanghai Junshi Biosciences went public on 12/11/2018 on the HKG
Listed Exchange:
HKG
IPO Date:
12/11/2018
IPO Valuation:
$450M
Ticker Symbol:
SHA
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 2/2021 | Coherus Biosciences | Post-IPO Equity | 50M |
| 12/2020 | IMPACT Therapeutics | Series C | 0 |
| 2/2021 | Zhishan Weixin Biotechnology | Series A | - |
| 7/2021 | GRIT Biotechnology | Series A | - |
| 7/2021 | GRIT Biotechnology | Series A | - |
| 2/2021 | Zhishan Weixin Biotechnology | Series A | - |
| 2/2021 | Coherus Biosciences | Post-IPO Equity | 0 |
| 12/2020 | IMPACT Therapeutics | Series C | 0 |
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
